Overview
Portfolio
More
4FOX Ventures
Lausanne, Switzerland
4FOX Ventures focuses on early‑stage Swiss healthcare and technology companies, acting as the first institutional investor and often leading or co‑leading the round. They provide deep operational expertise and industry n...
Portfolio
10+
Employees
3+
Founded
2017
AUM
N/A
Investment focus
Stages
Pre-Seed → Series A
Industries
Software OnlyHealthcare Technology
Geographic scope
Global
Sources
4FOX Ventures
4FOX Ventures focuses on early‑stage Swiss healthcare and technology companies, acting as the first institutional investor and often leading or co‑leading the round. They provide deep operational expertise and industry networks to help portfolio companies scale internationally. Their thesis emphasizes building trust, bridging cultural gaps, and supporting global market entry.
Portfolio
10+
Employees
3+
Founded
2017
AUM
N/A
Stages
Pre-Seed → Series A
Industries
Software OnlyHealthcare Technology
Geographic scope
Global
Sources
Showing 6 of 6 matched portfolio companies
Artiria Medical offers the SmartGUIDE guidewire, a 0.014 in × 200 cm neurovascular guidewire with a dynamic, deflectable tip that can be reshaped in situ via a single‑hand pusher button. The soft, atraumatic shaft and market‑leading hydrophilic coating provide smooth, low‑friction navigation through tortuous cerebral vessels while maintaining consistent torque transmission, improving procedural speed and accuracy for endovascular surgeons and interventional neuroradiologists.
Funding: $6.0M
Rough estimate of the amount of funding raised
Funding: $6.0M
Rough estimate of the amount of funding raised
Aspivix offers Carevix®, an FDA‑cleared, CE‑marked soft‑suction cervical stabilizer that replaces the traditional tenaculum in transcervical procedures. By using a gentle vacuum grip and one‑button release, the device reduces patient pain by over 70 % and bleeding by more than 80 % while maintaining procedural control, helping gynecologists improve comfort and efficiency during IUD insertions, hysteroscopies, and related procedures.
Funding: $7.7M
Rough estimate of the amount of funding raised
Funding: $7.7M
Rough estimate of the amount of funding raised
Ecorobotix offers an AI‑driven ultra‑high‑precision field sprayer that uses real‑time computer vision and deep‑learning classification to identify crops and weeds and apply micro‑doses only where needed. The compact unit mounts on standard tractor PTO, reduces herbicide use by up to 95 % and provides georeferenced treatment data for analytics and compliance reporting.
Funding: $105.0M
Rough estimate of the amount of funding raised
Funding: $105.0M
Rough estimate of the amount of funding raised
Giotto.ai is an AI lab focused on developing advanced reasoning technologies that move beyond traditional machine learning. The company creates adaptable AI capable of generalizing across tasks and solving problems with human-like flexibility. Their technology aims to achieve breakthroughs in contextual understanding and performance on benchmarks like ARC-AGI.
Funding: $2.8M
Rough estimate of the amount of funding raised
Funding: $2.8M
Rough estimate of the amount of funding raised
Positrigo develops the NeuroLF, an ultra-compact brain Positron Emission Tomography (PET) system designed for functional brain imaging. This technology aims to provide precision medicine for various neurological disorders, including dementia and neuro-oncology, at a significantly reduced cost. The company focuses on making advanced functional imaging accessible for broader clinical and research applications worldwide.
Funding: $13.9M
Rough estimate of the amount of funding raised
Funding: $13.9M
Rough estimate of the amount of funding raised
Scailyte provides an AI‑powered platform that integrates large‑scale single‑cell and spatial omics data with longitudinal clinical outcomes to identify disease‑driving cellular states and predictive biomarkers for autoimmune disorders. Using proprietary supervised representation learning, the platform delivers unbiased molecular patterns and high‑resolution patient endotypes, enabling pharma partners to accelerate target discovery, diagnostic development, and precision patient stratification.
Funding: $1.8M
Rough estimate of the amount of funding raised
Funding: $1.8M
Rough estimate of the amount of funding raised
Showing 4 of 4 unmatched portfolio companies